Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Jardiance reduced risk of kidney disease progression in adults with type 2 diabetes
June 25, 2018 Off

Jardiance reduced risk of kidney disease progression in adults with type 2 diabetes

By Dino Mustafić

Boehringer Ingelheim and Eli Lilly have shown consistent effects for Jardiance versus placebo on renal outcomes in patients with established…

Santhera’s Raxone Early Acces to Medicines Scheme renewed in UK
June 22, 2018 Off

Santhera’s Raxone Early Acces to Medicines Scheme renewed in UK

By Dino Mustafić

Santhera Pharmaceuticals’s Raxone has been renewed in UK, as the nation’s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed…

June 22, 2018 Off

Destiny Pharma names new non-executive director

By Dino Mustafić

Destiny Pharm has consolidate its board with appointing Nick Rodgers as an independent Non-Executive Director with immediate effect.

OptiBiotix secures 10 year presence of its LPLDL in Italy
June 21, 2018 Off

OptiBiotix secures 10 year presence of its LPLDL in Italy

By Dino Mustafić

OptiBiotix Health, a producer of obesity tackling products, and high cholesterol, diabetes and skin care, has ensured its cholesterol and…

Idorsia enrolls first patient into Precision phase 3 study of aprocitentan for resistant hypertension management in adults
June 20, 2018 Off

Idorsia enrolls first patient into Precision phase 3 study of aprocitentan for resistant hypertension management in adults

By Dino Mustafić

Idorsia has enrolled the first patient into its Phase 3 study called Precision to investigate the efficacy and safety of…

Novo Nordisk shows oral semaglutide more effective in lowering glucose and body weight than Victoza
June 20, 2018 Off

Novo Nordisk shows oral semaglutide more effective in lowering glucose and body weight than Victoza

By Dino Mustafić

Novo Nordisk on Wednesday said that it has completed headline results of the phase 3a trials PIONEER 4 comparing oral…

Sanofi wraps up €3,9 billion acquisition of Ablynx
June 19, 2018 Off

Sanofi wraps up €3,9 billion acquisition of Ablynx

By Dino Mustafić

Sanofi and Ablynx have completed the acquisition, as Sanofi has acquired all outstanding shares, warrants and convertible bonds of Ablynx.

Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
June 18, 2018 Off

Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery

By Dino Mustafić

Novartis’s eye care division Alcon unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ…

Idorsia starting study to test clazosentan in certain cereblar ischemia patients
June 18, 2018 Off

Idorsia starting study to test clazosentan in certain cereblar ischemia patients

By Dino Mustafić

Idorsia today is initiating a Phase 3 study React to test clazosentan for the prevention of clinical deterioration due to…

Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site
June 14, 2018 Off

Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

By Dino Mustafić

Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare…

Posts pagination

Previous 1 … 3,385 3,386 3,387 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine